Bufalin Enhances Anti-Angiogenic Effect of Sorafenib via AKT/VEGF Signaling

International Journal of Oncology - Greece
doi 10.3892/ijo.2016.3326
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Anti-Angiogenic Alternatives to VEGF Blockade

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2015English

MK2206 Enhances the Cytocidal Effects of Bufalin in Multiple Myeloma by Inhibiting the AKT/mTOR Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

Tankyrase Inhibition Enhances the Anti-Proliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting Β-Catenin and AKT Signaling in Colorectal Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2017English

Protein Kinase D1 Signaling in Angiogenic Gene Expression and VEGF-Mediated Angiogenesis

Frontiers in Cell and Developmental Biology
Developmental BiologyCell Biology
2016English

Serum Containing Tao-Hong-Si-Wu Decoction Induces Human Endothelial Cell VEGF Production via PI3K/Akt-eNOS Signaling

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2013English

Sorafenib Enhances the in Vitro Anti-Endothelial Effects of Low Dose (Metronomic) Chemotherapy

Oncology Reports
MedicineCancer ResearchOncology
2010English

CXCR4/CXCL12 Axis Promotes VEGF-mediated Tumor Angiogenesis Through Akt Signaling Pathway

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2007English

Pro‑apoptotic and Anti‑proliferative Effects of Mitofusin‑2 via PI3K/Akt Signaling in Breast Cancer Cells

Oncology Letters
Cancer ResearchOncology
2015English

Diacetyloxyl Derivatization of the Fibroblast Growth Factor Inhibitor Dobesilate Enhances Its Anti-Inflammatory, Anti-Angiogenic and Anti-Tumoral Activities

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy